The importance of diversity in clinical trials is well-documented, yet unfortunately the lack of diversity still occurs at an alarming rate. As a result, we continue to have less effective treatments, poorer health outcomes, one-size-fits-all medicine …
As a health care writer and data analyst, I hear frequently from patients who are being denied safe and effective pain care due to unscientific bias on the part of U.S. health care agencies—and sometimes on the part of otherwise once-reputable medical …
“Once it’s in your body, there’s no taking it back.” That’s what the infusion nurse told a friend of mine after administering the injection. She had just started a biologic medication for an autoimmune condition. Immediate…
Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes! Surgeon and author Jeffrey A. Singer discusses his article “The FDA’s outdated prescription rules are failing women and opioid users.” He argues that the…
Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes! Health care executive Gavin Magaha discusses his article “Advancing drug discount programs starts with collaboration and clarity.” He outlines how the 340B dru…
In a revealing snapshot of American mental health, the CDC recently reported that nearly 1 in 4 adults in the United States may be taking psychotropic medications. This staggering number should both draw attention and raise questions. Are we truly addr…
An excerpt from Your Body, Your Health Care. Tens of millions of American women—more than four out of five women who have had sexual intercourse—have used oral contraceptives, which are crucial for reducing unwanted pregnancies and the incidence of abo…
Everyone seems so scared of the word government regulation when it comes to health care. Why? In part, this is because those against regulations (everyone making money off health care) make sure to scare laypeople into equating such action with sociali…
The 340B drug discount program was enacted more than 30 years ago to lower the cost of medications so providers could deliver more comprehensive services for vulnerable patients. As care delivery has evolved greatly over that time, the program has not …
Across all industries, artificial intelligence is changing our approach to developing new products, including in the life sciences and drug development. While it may seem that an AI-derived treatment is far in the future, the science, biomathematics, a…
